Inactive/Delisted stock
Quoin Pharmaceuticals Stock (NASDAQ:QNRX)
Previous Close
$19.24
52W Range
$5.01 - $48.30
50D Avg
$10.69
200D Avg
$9.04
Market Cap
$11.07M
Avg Vol (3M)
$617.77K
Beta
1.96
Div Yield
-
QNRX Company Profile
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.